{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:16:14Z","timestamp":1790046974572,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.cancergencyto.2005.12.010","type":"journal-article","created":{"date-parts":[[2006,6,13]],"date-time":"2006-06-13T14:50:55Z","timestamp":1150210255000},"page":"59-68","source":"Crossref","is-referenced-by-count":4,"title":["Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam"],"prefix":"10.1016","volume":"168","author":[{"given":"Phan Thi","family":"Xinh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Anh","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huynh","family":"Van Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Khanh","family":"Tri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Tan","family":"Binh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huynh","family":"Nghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Quy","family":"Trong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran","family":"Van Binh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran","family":"Van Be","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2005.12.010_bib1","first-page":"751","article-title":"The molecular biology of chronic myeloid leukaemia","volume":"10","author":"Melo","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.1988.6.1.180","article-title":"Definition of the accelerated phase of chronic myelogenous leukemia","volume":"6","author":"Kantarjian","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/1097-0142(197101)27:1<176::AID-CNCR2820270125>3.0.CO;2-B","article-title":"Chromosomes and causation of human cancer and leukemia: VI. Blastic phase, cellular origin, and the Ph1 in CML","volume":"27","author":"Sandberg","year":"1971","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ijc.2910180105","article-title":"Non-random karyotypic evolution in chronic myeloid leukemia","volume":"18","author":"Mitelman","year":"1976","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(87)90754-6","article-title":"Chronic myelogenous leukemia in blast crisis: analysis of 242 patients","volume":"83","author":"Kantarjian","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib6","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/blood.V81.1.158.158","article-title":"The ABL-BCR fusion gene is expressed in chronic myeloid leukemia","volume":"81","author":"Melo","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0041-008X(78)90075-3","article-title":"Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats","volume":"46","author":"Kociba","year":"1978","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5271\/sjweh.2631","article-title":"Herbicide exposure and tumor mortality: an updated epidemiologic investigation on Swedish railroad workers","volume":"6","author":"Axelson","year":"1980","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5271\/sjweh.2160","article-title":"Health effects of phenoxy herbicides: a review","volume":"12","author":"Sterling","year":"1986","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib11","first-page":"91","article-title":"Reclassification of leukemia among A-bomb survivors in Nagasaki using French\u2013American\u2013British (FAB) classification for acute leukemia","volume":"18","author":"Matsuo","year":"1988","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib12","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2307\/3578893","article-title":"Cancer incidence in atomic bomb survivors: III. Leukemia, lymphoma and multiple myeloma, 1950\u20131987","volume":"137","author":"Preston","year":"1994","journal-title":"Radiat Res"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib13","first-page":"9","article-title":"General status of chronic myeloid leukemia at Blood Transfusion and Hematology Hospital in southern Vietnam","volume":"5","author":"Tuan","year":"2002","journal-title":"J Vietnam Med"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib14","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/blood.V84.12.4064.bloodjournal84124064","article-title":"The German CML Study Group. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia","volume":"84","author":"Hehlmann","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cancergencyto.2005.07.012","article-title":"Coexistence of Philadelphia chromosome positive cells with and without der(9) deletion in patient with chronic myelogenous leukemia","volume":"164","author":"Xinh","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2141.1997.102652.x","article-title":"German Chronic Myeloid Leukaemia (CML)-Study Group. Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score","volume":"97","author":"Hehlmann","year":"1997","journal-title":"Br J Haematol"},{"issue":"Suppl 3","key":"10.1016\/j.cancergencyto.2005.12.010_bib18","first-page":"S15","article-title":"Progress with interferon in CML: results of the MRC UK CML III Study","volume":"17","author":"Shepherd","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib19","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V98.6.1732","article-title":"Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia","volume":"98","author":"Huntly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib20","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood-2003-01-0123","article-title":"Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia","volume":"102","author":"Huntly","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib21","unstructured":"Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer. Updated May 2005. Available at: http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman."},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib22","first-page":"928","article-title":"Detection of molecular variants of Bcr-Abl gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR)","volume":"83","author":"Udomsakdi-Auewarakul","year":"2000","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib23","first-page":"457","article-title":"BCR-ABL mRNA lacking Abl exon a2 detected by polymerase chain reaction in a chronic myelogeneous leukemia patient","volume":"5","author":"van der Plas","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib24","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1182\/blood.V99.12.4547","article-title":"Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability","volume":"99","author":"Huntly","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib25","first-page":"305","article-title":"First International Workshop on Chromosomes in Leukaemia","volume":"39","author":"Chromosomes in Ph1-positive chronic granulocytic leukemia","year":"1978","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/blood.V82.3.691.691","article-title":"Chronic myelogenous leukemia: a concise update","volume":"82","author":"Kantarjian","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib27","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1182\/blood.V97.11.3581","article-title":"Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis","volume":"97","author":"Kolomietz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jnci\/90.11.850","article-title":"Writing Committee for the Collaborative CML Prognostic Factors Project Group. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa","volume":"90","author":"Hasford","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0165-4608(99)00067-9","article-title":"Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive","volume":"114","author":"Yehuda","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-4608(02)00662-3","article-title":"Chimeric BCR\/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia","volume":"141","author":"Costa","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2005.12.010_bib31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2105\/AJPH.85.4.516","article-title":"Agent Orange and the Vietnamese: the persistence of elevated dioxin levels in human tissues","volume":"85","author":"Schecter","year":"1995","journal-title":"Am J Public Health"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805007430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805007430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T12:35:03Z","timestamp":1586954103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460805007430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0165460805007430"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2005.12.010","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}